|
VPS13C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.641680E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.877500E-03 |
| Normal-vs-Stage2 |
6.965800E-02 |
| Normal-vs-Stage3 |
1.600120E-02 |
| Normal-vs-Stage4 |
1.672480E-02 |
| Stage1-vs-Stage2 |
8.971600E-01 |
| Stage1-vs-Stage3 |
6.271000E-01 |
| Stage1-vs-Stage4 |
4.583800E-01 |
| Stage2-vs-Stage3 |
6.279400E-01 |
| Stage2-vs-Stage4 |
4.318200E-01 |
| Stage3-vs-Stage4 |
6.919000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.396400E-03 |
| Normal-vs-AfricanAmerican |
4.568200E-02 |
| Normal-vs-Asian |
4.856100E-02 |
| Caucasian-vs-AfricanAmerican |
4.751600E-01 |
| Caucasian-vs-Asian |
6.730600E-01 |
| AfricanAmerican-vs-Asian |
5.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.562200E-04 |
| Normal-vs-Female |
6.397000E-01 |
| Male-vs-Female |
1.739250E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.375700E-02 |
| Normal-vs-Extreme_Weight |
8.11360000000372E-05 |
| Normal-vs-Obese |
1.756970E-01 |
| Normal-vs-Extreme_Obese |
2.021600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.627400E-01 |
| Normal_Weight-vs-Obese |
3.591600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.761600E-01 |
| Extreme_Weight-vs-Obese |
6.898400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.089200E-01 |
| Obese-vs-Extreme_Obese |
2.810600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.713220E-01 |
| Normal-vs-Age(41-60Yrs) |
8.144200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.984650E-03 |
| Normal-vs-Age(81-100Yrs) |
8.154200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.841000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.228000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.242300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.163800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.876500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.166200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.263400E-03 |
| Normal-VS-Type2 PRCC |
3.803000E-03 |
| Normal-VS-KIRP CIMP |
4.070600E-01 |
| Normal-VS-Unclassified PRCC |
6.466000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.599000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.484600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.542200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.899400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.265900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.278800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.44309999999359E-05 |
| Normal-vs-N1 |
1.561960E-02 |
| Normal-vs-N2 |
2.406800E-01 |
| N0-vs-N1 |
4.094600E-01 |
| N0-vs-N2 |
5.982000E-01 |
| N1-vs-N2 |
9.374400E-01 |
|
|
